Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             57 results found
no title author magazine year volume issue page(s) type
1 A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies Rini, Brian
2015
16 6 p. 676-685
10 p.
article
2 Air pollution, climate change, and health Gibson, Josefine
2015
16 6 p. e269-
1 p.
article
3 Antibody–drug conjugates in non-Hodgkin lymphoma Lim, Soon Thye
2015
16 6 p. 607-608
2 p.
article
4 Anti-PD-L1 for metastatic triple-negative breast cancer Gibson, Josefine
2015
16 6 p. e264-
1 p.
article
5 Aprepitant for paediatric chemotherapy-induced nausea and vomiting Batra, Atul
2015
16 6 p. e259-e260
nvt p.
article
6 Aprepitant for paediatric chemotherapy-induced nausea and vomiting Slimano, Florian
2015
16 6 p. e259-
1 p.
article
7 Aprepitant for paediatric chemotherapy-induced nausea and vomiting – Authors' reply Green, Stuart
2015
16 6 p. e560-e561
nvt p.
article
8 ASTRO issues new guidance for radiotherapy in NSCLC Yaqub, Farhat
2015
16 6 p. e268-
1 p.
article
9 Bevacizumab: the phoenix of breast oncology? Andre, Fabrice
2015
16 6 p. 600-601
2 p.
article
10 CA-125 blood test in early detection of ovarian cancer Burki, Talha Khan
2015
16 6 p. e269-
1 p.
article
11 Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis Blanchard, Pierre
2015
16 6 p. 645-655
11 p.
article
12 Children with advanced cancer need symptomatic treatments Bagcchi, Sanjeet
2015
16 6 p. e266-
1 p.
article
13 Clinical implications of genomics for cancer risk genetics Thomas, David M
2015
16 6 p. e303-e308
nvt p.
article
14 Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis Cybulski, Cezary
2015
16 6 p. 638-644
7 p.
article
15 Controversies in defining cancer survivorship Dirven, Linda
2015
16 6 p. 610-612
3 p.
article
16 Correction to Lancet Oncol 2015; 16: 522–30 2015
16 6 p. e262-
1 p.
article
17 Correction to Lancet Oncol 2015; 16: 499–508 2015
16 6 p. e262-
1 p.
article
18 Correction to Lancet Oncol 2015; 16: 324 2015
16 6 p. e262-
1 p.
article
19 Correction to Lancet Oncol 2014; 15: 1324 2015
16 6 p. e262-
1 p.
article
20 Effect of PALB2 status on breast cancer precision medicine Delaloge, Suzette
2015
16 6 p. 598-600
3 p.
article
21 Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial Earl, Helena M
2015
16 6 p. 656-666
11 p.
article
22 Generic drug market: growing and merging The Lancet Oncology,
2015
16 6 p. 595-
1 p.
article
23 Hepatitis C virus associated with high rates of cancer Burki, Talha Khan
2015
16 6 p. e266-
1 p.
article
24 Immunotherapy combination promising for melanomas Brower, Vicki
2015
16 6 p. e265-
1 p.
article
25 Negative PET: good prognosis for Hodgkin's lymphoma Bagcchi, Sanjeet
2015
16 6 p. e265-
1 p.
article
26 Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies Northcott, Paul A
2015
16 6 p. e293-e302
nvt p.
article
27 Panobinostat active against diffuse intrinsic pontine glioma Bagcchi, Sanjeet
2015
16 6 p. e267-
1 p.
article
28 Parenthood in adult female survivors treated for Hodgkin's lymphoma during childhood and adolescence: a prospective, longitudinal study Brämswig, Jürgen H
2015
16 6 p. 667-675
9 p.
article
29 Parenthood in female survivors of Hodgkin's lymphoma Wallace, W Hamish
2015
16 6 p. 601-603
3 p.
article
30 Pattern of change in telomere length: possible predictor of cancer Tanday, Sanjay
2015
16 6 p. e267-
1 p.
article
31 Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study Phan, Alexandria T
2015
16 6 p. 695-703
9 p.
article
32 Pazopanib: a new drug for pancreatic neuroendocrine tumours Kwekkeboom, Dik J
2015
16 6 p. 606-607
2 p.
article
33 Pembrolizumab for patients with advanced melanoma Burki, Talha Khan
2015
16 6 p. e264-
1 p.
article
34 Positive death: the third wave Harrison, Natalie
2015
16 6 p. 616-
1 p.
article
35 Potential new treatments for EGFR-inhibitor-resistant NSCLC Yaqub, Farhat
2015
16 6 p. e268-
1 p.
article
36 Prognostication in localised renal cell carcinoma Kroeger, Nils
2015
16 6 p. 603-604
2 p.
article
37 Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial Li, Jin
2015
16 6 p. 619-629
11 p.
article
38 Repeal of SGR: US payment reform for Medicare reimbursement Nierengarten, Mary Beth
2015
16 6 p. 613-
1 p.
article
39 Reporting of results in DART01/05 GICOR Pisansky, Thomas M
2015
16 6 p. e258-
1 p.
article
40 Reporting of results in DART01/05 GICOR – Author's reply Zapatero, Almudena
2015
16 6 p. e258-e259
nvt p.
article
41 Response assessment criteria for brain metastases: proposal from the RANO group Lin, Nancy U
2015
16 6 p. e270-e278
nvt p.
article
42 SABR in early operable lung cancer: time for evidence Treasure, Tom
2015
16 6 p. 597-598
2 p.
article
43 Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study Palanca-Wessels, Maria Corinna A
2015
16 6 p. 704-715
12 p.
article
44 Second-line dovitinib in metastatic endometrial cancer Block, Matthew S
2015
16 6 p. 604-606
3 p.
article
45 Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study Konecny, Gottfried E
2015
16 6 p. 686-694
9 p.
article
46 Sequencing of agents in castration-resistant prostate cancer Lorente, David
2015
16 6 p. e279-e292
nvt p.
article
47 So It Goes Coburn, Cassandra
2015
16 6 p. 618-
1 p.
article
48 Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Chang, Joe Y
2015
16 6 p. 630-637
8 p.
article
49 Systemic therapy for advanced basal cell carcinoma Maybury, Catriona M
2015
16 6 p. 608-610
3 p.
article
50 Thank You For Playing van Dorn, Aaron
2015
16 6 p. 615-
1 p.
article
51 The genesis of the Saving Faces art project Sansom, Clare
2015
16 6 p. 617-618
2 p.
article
52 The role of regorafenib in metastatic colorectal cancer Riechelmann, Rachel
2015
16 6 p. 596-597
2 p.
article
53 Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial Migden, Michael R
2015
16 6 p. 716-728
13 p.
article
54 UK Research Councils' new funding criteria for animal studies Xanthos, Dimitris
2015
16 6 p. e263-
1 p.
article
55 Use of chemotherapy in patients with metastatic lung cancer Bagcchi, Sanjeet
2015
16 6 p. e263-
1 p.
article
56 US National Cancer Institute investigates PSA coding errors Furlow, Bryant
2015
16 6 p. 614-
1 p.
article
57 Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial Basset-Seguin, Nicole
2015
16 6 p. 729-736
8 p.
article
                             57 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands